Journal of the American Chemical Society,
Год журнала:
2019,
Номер
141(16), С. 6553 - 6560
Опубликована: Апрель 4, 2019
Targeted
covalent
inhibitor
design
is
gaining
increasing
interest
and
acceptance.
A
typical
kinase
targets
a
reactive
cysteine;
however,
this
strategy
limited
by
the
low
abundance
of
cysteine
acquired
drug
resistance
from
point
mutations.
Inspired
recent
development
lysine-targeted
chemical
probes,
we
asked
if
nucleophilic
(reactive)
catalytic
lysines
are
common
on
basis
published
crystal
structures
human
kinome.
Using
newly
developed
pKa
prediction
tool
based
continuous
constant
pH
molecular
dynamics,
eight
unique
kinases
various
groups
were
retrospectively
prospectively
predicted
to
be
nucleophilic,
when
in
rare
DFG-out/αC-out
type
conformation.
Importantly,
other
as
well
cysteines
at
locations
also
identified.
On
findings,
proposed
new
which
selective
II
reversible
inhibitors
modified
highly
selective,
inhibitors.
Traditional
drugs
discovered
serendipitously;
presented
tool,
can
assess
reactivities
any
potentially
targetable
residues,
may
accelerate
rational
discovery
Another
significant
finding
work
that
adopt
neutral
charged
states
physiological
pH,
respectively.
This
shift
current
paradigm
computational
studies
kinases,
assume
fixed
solution
protonation
states.
Journal of Medicinal Chemistry,
Год журнала:
2019,
Номер
62(11), С. 5616 - 5627
Опубликована: Май 16, 2019
We
have
recently
reported
a
series
of
Lys-covalent
agents
targeting
the
BIR3
domain
X-linked
inhibitor
apoptosis
protein
(XIAP)
using
benzamide-sulfonyl
fluoride
warhead.
Using
XIAP
as
model
system,
we
further
investigated
variety
additional
warheads
that
can
be
easily
incorporated
into
binding
peptides
and
analyzed
their
ability
to
form
covalent
adducts
with
lysine
other
amino
acids,
including
tyrosine,
histidine,
serine,
threonine,
biochemical
biophysical
assays.
Moreover,
tested
aqueous,
plasma
stability,
cell
permeability,
cellular
efficacy
most
effective
agents.
These
studies
identified
aryl-fluoro
sulfates
likely
suitable
electrophiles
effectively
Lys,
Tyr,
His
residues,
given
these
were
permeable
stable
in
aqueous
buffer
plasma.
Our
contain
number
general
findings
open
new
possible
avenues
for
design
potent
protein–protein
interaction
antagonists.
ACS Central Science,
Год журнала:
2020,
Номер
6(4), С. 546 - 554
Опубликована: Апрель 13, 2020
Covalent
inhibitors
have
recently
seen
a
resurgence
of
interest
in
drug
development.
Nevertheless,
compounds,
which
do
not
rely
on
an
enzymatic
activity,
almost
exclusively
been
developed
to
target
cysteines.
Expanding
the
scope
other
amino
acids
would
be
largely
facilitated
by
ability
globally
monitor
their
engagement
covalent
inhibitors.
Here,
we
present
use
light-activatable
2,5-disubstituted
tetrazoles
that
allow
quantifying
8971
aspartates
and
glutamates
bacterial
proteome
with
excellent
selectivity.
Using
these
probes,
competitively
map
binding
sites
two
isoxazolium
salts
introduce
hydrazonyl
chlorides
as
new
class
carboxylic-acid-directed
protein
ligands.
As
probes
are
unreactive
prior
activation,
they
global
profiling
even
living
Gram-positive
Gram-negative
bacteria.
Taken
together,
this
method
proteome-wide
will
lay
foundation
efficiently
develop
targeting
acids.
Angewandte Chemie International Edition,
Год журнала:
2019,
Номер
59(7), С. 2829 - 2836
Опубликована: Ноя. 29, 2019
Abstract
Rapid
development
of
bacterial
resistance
has
led
to
an
urgent
need
find
new
druggable
targets
for
antibiotics.
In
this
context,
residue‐specific
chemoproteomic
approaches
enable
proteome‐wide
identification
binding
sites
covalent
inhibitors.
Described
here
are
easily
synthesized
isotopically
labeled
desthiobiotin
azide
(isoDTB)
tags
that
shortened
the
workflow
and
allowed
increased
coverage
cysteines
in
systems.
They
were
used
quantify
59
%
all
essential
proteins
Staphylococcus
aureus
enabled
discovery
88
showed
high
reactivity,
which
correlates
with
functional
importance.
Furthermore,
268
engaged
by
ligands
identified.
Inhibition
HMG‐CoA
synthase
was
verified
will
allow
addressing
mevalonate
pathway
through
a
target.
Overall,
broad
map
cysteinome
obtained,
facilitate
antibiotics
novel
modes‐of‐action.
Journal of Medicinal Chemistry,
Год журнала:
2021,
Номер
65(1), С. 58 - 83
Опубликована: Дек. 28, 2021
Small
molecule
covalent
kinase
inhibitors
(CKIs)
have
entered
a
new
era
in
drug
discovery,
which
the
advantage
for
sustained
target
inhibition
and
high
selectivity.
An
increased
understanding
of
binding
kinetics
CKIs
discovery
additional
irreversible
reversible-covalent
cysteine-targeted
warheads
has
inspired
development
this
area.
Herein,
we
summarize
major
medicinal
chemistry
strategies
employed
these
representative
CKIs,
are
categorized
by
location
cysteine
within
seven
main
regions
kinase:
front
region,
glycine
rich
loop
(P-loop),
hinge
DFG
activation
(A-loop),
catalytic
(C-loop),
remote
loop.
The
emphasis
is
placed
on
design
optimization
that
generated
addition
warhead
to
reversible
lead/inhibitor
scaffold.
In
addition,
address
challenges
facing
area
discovery.
Drug Discovery Today,
Год журнала:
2020,
Номер
25(6), С. 983 - 996
Опубликована: Апрель 13, 2020
Targeted
covalent
inhibitors
and
chemical
probes
have
become
integral
parts
of
drug
discovery
approaches.
Given
the
advantages
fragment-based
discovery,
screening
electrophilic
fragments
emerged
as
a
promising
alternative
to
discover
validate
novel
targets
generate
viable
starting
points
even
for
that
are
barely
tractable.
In
this
review,
we
present
recent
principles
considerations
in
design
fragment
libraries
from
selection
appropriate
warhead
through
compilation
library.
We
then
summarize
methodologies
against
surrogate
models,
proteins,
whole
proteome,
or
living
cells.
Finally,
highlight
applications
libraries.